China Shineway Pharmaceutical Group (HKG:2877) recorded a turnover of 2.89 billion yuan for the nine months ended Sept. 30, down 16.9% from the year-ago period, a Friday filing said.
The pharmaceutical company's injection, soft capsule, granule, and TCM formula granule products accounted for around 35.6%, 13.5%, 15.8%, and 28.5%, respectively, of the total turnover.
The company's shares were down over 1% in recent trade.
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。